Genfit SA (GNFT) Earnings Date & Reports

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GNFT is expected to report earnings to fall 126.20% to 11 cents per share on September 22

Q2'25

Est.

$0.11

Q4'24

Beat

by $0.02

Q2'24

Beat

by $0.25

The last earnings report on April 24 showed earnings per share of -43 cents, beating the estimate of -45 cents. With 12.19K shares outstanding, the current market capitalization sits at 226.24M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GNFT (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Parc Eurasante

Phone

+33 320164000

Employees

148

Web

https://www.genfit.com